Nanotherapeutics: from laboratory to clinic
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Boca Raton ; London ; New York
CRC Press, Taylor & Francis Group
[2016]
|
| Schlagworte: | |
| Beschreibung: | xvii, 336 Seiten Illustrationen |
| ISBN: | 9781498707510 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV043861287 | ||
| 003 | DE-604 | ||
| 005 | 20221014 | ||
| 007 | t | ||
| 008 | 161104s2016 a||| |||| 00||| eng d | ||
| 020 | |a 9781498707510 |c print |9 978-1-498-70751-0 | ||
| 035 | |a (OCoLC)965511319 | ||
| 035 | |a (DE-599)BVBBV043861287 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-29T | ||
| 100 | 1 | |a Chowdhury, Ezharul Hoque |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Nanotherapeutics |b from laboratory to clinic |c Ezharul H. Chowdhury, Monash University(Sunway campus), Malaysia |
| 264 | 1 | |a Boca Raton ; London ; New York |b CRC Press, Taylor & Francis Group |c [2016] | |
| 264 | 4 | |c © 2016 | |
| 300 | |a xvii, 336 Seiten |b Illustrationen | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 505 | 8 | |a Includes bibliographical references and index | |
| 505 | 8 | |a Chapter 1. Emergence of nanotherapeutics : challenges in classical drug transport versus macromolecular drug design -- chapter 2. The ultimate destinations for delivery and release of nanotherapeutics -- chapter 3. Diversity of bioactive nanoparticles from biological, chemical, and physical perspectives -- chapter 4. Fabrication strategies for biofunctional nanoparticles -- chapter 5. Interactions and orientation of therapeutic drugs in the vicinity of nanoparticles -- chapter 6. Variable interactions of nanoparticles with blood, lymph, and extracellular and intracellular components -- chapter 7. Pharmacokinetics and biodistribution of nanoparticles -- chapter 8. Specific roles of nanoparticles in various steps of drug transport -- chapter 9. Nanotechnology approaches to modulate transport, release, and bioavailability of classical and emerging therapeutics -- chapter 10. Nanotechnology in the development of innovative treatment strategies -- chapter 11. Nanoparticles for therapeutic delivery in animal models of different cancers -- chapter 12. Nanoparticles for therapeutic delivery in animal models of other critical human diseases -- chapter 13. Nanomedicine in clinical trials -- chapter 14. Approved and commercialized nanomedicine -- chapter 15. Current safety issues : biodegradability, reactivity, and clearance | |
| 650 | 4 | |a Nanoparticles / therapeutic use | |
| 650 | 4 | |a Drug Delivery Systems | |
| 650 | 4 | |a Molecular Targeted Therapy | |
| 650 | 4 | |a Nanomedicine | |
| 650 | 4 | |a Nanoparticles / Therapeutic use | |
| 650 | 4 | |a Drug delivery systems | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-1-03-233999-3 |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029271377 | ||
Datensatz im Suchindex
| _version_ | 1804176741723275264 |
|---|---|
| any_adam_object | |
| author | Chowdhury, Ezharul Hoque |
| author_facet | Chowdhury, Ezharul Hoque |
| author_role | aut |
| author_sort | Chowdhury, Ezharul Hoque |
| author_variant | e h c eh ehc |
| building | Verbundindex |
| bvnumber | BV043861287 |
| contents | Includes bibliographical references and index Chapter 1. Emergence of nanotherapeutics : challenges in classical drug transport versus macromolecular drug design -- chapter 2. The ultimate destinations for delivery and release of nanotherapeutics -- chapter 3. Diversity of bioactive nanoparticles from biological, chemical, and physical perspectives -- chapter 4. Fabrication strategies for biofunctional nanoparticles -- chapter 5. Interactions and orientation of therapeutic drugs in the vicinity of nanoparticles -- chapter 6. Variable interactions of nanoparticles with blood, lymph, and extracellular and intracellular components -- chapter 7. Pharmacokinetics and biodistribution of nanoparticles -- chapter 8. Specific roles of nanoparticles in various steps of drug transport -- chapter 9. Nanotechnology approaches to modulate transport, release, and bioavailability of classical and emerging therapeutics -- chapter 10. Nanotechnology in the development of innovative treatment strategies -- chapter 11. Nanoparticles for therapeutic delivery in animal models of different cancers -- chapter 12. Nanoparticles for therapeutic delivery in animal models of other critical human diseases -- chapter 13. Nanomedicine in clinical trials -- chapter 14. Approved and commercialized nanomedicine -- chapter 15. Current safety issues : biodegradability, reactivity, and clearance |
| ctrlnum | (OCoLC)965511319 (DE-599)BVBBV043861287 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02597nam a2200373 c 4500</leader><controlfield tag="001">BV043861287</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20221014 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">161104s2016 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781498707510</subfield><subfield code="c">print</subfield><subfield code="9">978-1-498-70751-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)965511319</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043861287</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29T</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chowdhury, Ezharul Hoque</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nanotherapeutics</subfield><subfield code="b">from laboratory to clinic</subfield><subfield code="c">Ezharul H. Chowdhury, Monash University(Sunway campus), Malaysia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton ; London ; New York</subfield><subfield code="b">CRC Press, Taylor & Francis Group</subfield><subfield code="c">[2016]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xvii, 336 Seiten</subfield><subfield code="b">Illustrationen</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Chapter 1. Emergence of nanotherapeutics : challenges in classical drug transport versus macromolecular drug design -- chapter 2. The ultimate destinations for delivery and release of nanotherapeutics -- chapter 3. Diversity of bioactive nanoparticles from biological, chemical, and physical perspectives -- chapter 4. Fabrication strategies for biofunctional nanoparticles -- chapter 5. Interactions and orientation of therapeutic drugs in the vicinity of nanoparticles -- chapter 6. Variable interactions of nanoparticles with blood, lymph, and extracellular and intracellular components -- chapter 7. Pharmacokinetics and biodistribution of nanoparticles -- chapter 8. Specific roles of nanoparticles in various steps of drug transport -- chapter 9. Nanotechnology approaches to modulate transport, release, and bioavailability of classical and emerging therapeutics -- chapter 10. Nanotechnology in the development of innovative treatment strategies -- chapter 11. Nanoparticles for therapeutic delivery in animal models of different cancers -- chapter 12. Nanoparticles for therapeutic delivery in animal models of other critical human diseases -- chapter 13. Nanomedicine in clinical trials -- chapter 14. Approved and commercialized nanomedicine -- chapter 15. Current safety issues : biodegradability, reactivity, and clearance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanoparticles / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Delivery Systems</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molecular Targeted Therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanomedicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanoparticles / Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug delivery systems</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-1-03-233999-3</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029271377</subfield></datafield></record></collection> |
| id | DE-604.BV043861287 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T07:37:00Z |
| institution | BVB |
| isbn | 9781498707510 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029271377 |
| oclc_num | 965511319 |
| open_access_boolean | |
| owner | DE-29T |
| owner_facet | DE-29T |
| physical | xvii, 336 Seiten Illustrationen |
| publishDate | 2016 |
| publishDateSearch | 2016 |
| publishDateSort | 2016 |
| publisher | CRC Press, Taylor & Francis Group |
| record_format | marc |
| spelling | Chowdhury, Ezharul Hoque Verfasser aut Nanotherapeutics from laboratory to clinic Ezharul H. Chowdhury, Monash University(Sunway campus), Malaysia Boca Raton ; London ; New York CRC Press, Taylor & Francis Group [2016] © 2016 xvii, 336 Seiten Illustrationen txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index Chapter 1. Emergence of nanotherapeutics : challenges in classical drug transport versus macromolecular drug design -- chapter 2. The ultimate destinations for delivery and release of nanotherapeutics -- chapter 3. Diversity of bioactive nanoparticles from biological, chemical, and physical perspectives -- chapter 4. Fabrication strategies for biofunctional nanoparticles -- chapter 5. Interactions and orientation of therapeutic drugs in the vicinity of nanoparticles -- chapter 6. Variable interactions of nanoparticles with blood, lymph, and extracellular and intracellular components -- chapter 7. Pharmacokinetics and biodistribution of nanoparticles -- chapter 8. Specific roles of nanoparticles in various steps of drug transport -- chapter 9. Nanotechnology approaches to modulate transport, release, and bioavailability of classical and emerging therapeutics -- chapter 10. Nanotechnology in the development of innovative treatment strategies -- chapter 11. Nanoparticles for therapeutic delivery in animal models of different cancers -- chapter 12. Nanoparticles for therapeutic delivery in animal models of other critical human diseases -- chapter 13. Nanomedicine in clinical trials -- chapter 14. Approved and commercialized nanomedicine -- chapter 15. Current safety issues : biodegradability, reactivity, and clearance Nanoparticles / therapeutic use Drug Delivery Systems Molecular Targeted Therapy Nanomedicine Nanoparticles / Therapeutic use Drug delivery systems Erscheint auch als Druck-Ausgabe, Hardcover 978-1-03-233999-3 |
| spellingShingle | Chowdhury, Ezharul Hoque Nanotherapeutics from laboratory to clinic Includes bibliographical references and index Chapter 1. Emergence of nanotherapeutics : challenges in classical drug transport versus macromolecular drug design -- chapter 2. The ultimate destinations for delivery and release of nanotherapeutics -- chapter 3. Diversity of bioactive nanoparticles from biological, chemical, and physical perspectives -- chapter 4. Fabrication strategies for biofunctional nanoparticles -- chapter 5. Interactions and orientation of therapeutic drugs in the vicinity of nanoparticles -- chapter 6. Variable interactions of nanoparticles with blood, lymph, and extracellular and intracellular components -- chapter 7. Pharmacokinetics and biodistribution of nanoparticles -- chapter 8. Specific roles of nanoparticles in various steps of drug transport -- chapter 9. Nanotechnology approaches to modulate transport, release, and bioavailability of classical and emerging therapeutics -- chapter 10. Nanotechnology in the development of innovative treatment strategies -- chapter 11. Nanoparticles for therapeutic delivery in animal models of different cancers -- chapter 12. Nanoparticles for therapeutic delivery in animal models of other critical human diseases -- chapter 13. Nanomedicine in clinical trials -- chapter 14. Approved and commercialized nanomedicine -- chapter 15. Current safety issues : biodegradability, reactivity, and clearance Nanoparticles / therapeutic use Drug Delivery Systems Molecular Targeted Therapy Nanomedicine Nanoparticles / Therapeutic use Drug delivery systems |
| title | Nanotherapeutics from laboratory to clinic |
| title_auth | Nanotherapeutics from laboratory to clinic |
| title_exact_search | Nanotherapeutics from laboratory to clinic |
| title_full | Nanotherapeutics from laboratory to clinic Ezharul H. Chowdhury, Monash University(Sunway campus), Malaysia |
| title_fullStr | Nanotherapeutics from laboratory to clinic Ezharul H. Chowdhury, Monash University(Sunway campus), Malaysia |
| title_full_unstemmed | Nanotherapeutics from laboratory to clinic Ezharul H. Chowdhury, Monash University(Sunway campus), Malaysia |
| title_short | Nanotherapeutics |
| title_sort | nanotherapeutics from laboratory to clinic |
| title_sub | from laboratory to clinic |
| topic | Nanoparticles / therapeutic use Drug Delivery Systems Molecular Targeted Therapy Nanomedicine Nanoparticles / Therapeutic use Drug delivery systems |
| topic_facet | Nanoparticles / therapeutic use Drug Delivery Systems Molecular Targeted Therapy Nanomedicine Nanoparticles / Therapeutic use Drug delivery systems |
| work_keys_str_mv | AT chowdhuryezharulhoque nanotherapeuticsfromlaboratorytoclinic |